ARIAD PHARMACEUTICALS INC's ticker is ARIA and the CUSIP is 04033A100. A total of 180 filers reported holding ARIAD PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.88 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $733,000 | +14.7% | 99,213 | -0.8% | 0.33% | +14.7% |
Q1 2016 | $639,000 | +1.6% | 100,038 | -0.7% | 0.28% | +3.6% |
Q4 2015 | $629,000 | +7.7% | 100,698 | +0.7% | 0.28% | +8.3% |
Q3 2015 | $584,000 | -49.9% | 99,963 | -29.0% | 0.25% | -53.1% |
Q2 2015 | $1,165,000 | -18.2% | 140,870 | -18.5% | 0.54% | -20.6% |
Q1 2015 | $1,424,000 | +20.2% | 172,875 | +0.2% | 0.68% | +16.8% |
Q4 2014 | $1,185,000 | +19.9% | 172,475 | -5.7% | 0.58% | +17.2% |
Q3 2014 | $988,000 | +4.4% | 182,975 | +23.3% | 0.50% | +6.4% |
Q2 2014 | $946,000 | +827.5% | 148,450 | +1078.2% | 0.47% | +819.6% |
Q1 2014 | $102,000 | – | 12,600 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 12,850,000 | $69,390,000 | 26.80% |
Opaleye Management Inc. | 1,500,000 | $8,100,000,000 | 6.31% |
Camber Capital Management LP | 6,000,000 | $32,400,000 | 3.04% |
Ghost Tree Capital, LLC | 700,000 | $3,780,000 | 2.05% |
Granite Point Capital Management, L.P. | 700,000 | $3,780,000 | 1.88% |
Duquesne Family Office | 1,645,000 | $8,883,000 | 1.09% |
Geduld E E | 272,200 | $1,470,000 | 1.04% |
Elk Creek Partners, LLC | 659,232 | $3,560,000 | 0.93% |
Palo Alto Investors LP | 2,231,717 | $12,051,000 | 0.90% |
HighVista Strategies LLC | 1,200,000 | $6,480,000 | 0.87% |